Cite
HARVARD Citation
Zhang, M. et al. (n.d.). A randomized, placebo‐controlled study of the pharmacokinetics, pharmacodynamics, and tolerability of the oral JAK2 inhibitor fedratinib (SAR302503) in healthy volunteers. Journal of clinical pharmacology. pp. 415-421. [Online].